NutriBand Inc. (NTRB) intrinsic value & 10-year financials

NutriBand Inc. (NTRB) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 17.3% a year to $2.0M, with an average return on invested capital of 32983.6%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$6.22
Market cap
$72.4M
Revenue (FY2026)
$2.0M
Revenue growth (10-yr CAGR)
17.3%
ROIC (10-yr avg)
32983.6%
Free cash flow (FY2026)
-$5.1M

NTRB 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2026 $2.0M -$8.2M -$2.58 -$5.1M -408.4% -382.3%
FY2025 $2.1M -$10.5M -$0.99 -$4.7M -480.7% -162.9%
FY2024 $2.1M -$5.5M -$0.69 -$3.6M -233.6% -82.4%
FY2023 $1.8M -$4.5M -$0.53 -$3.1M -250.6% -67.4%
FY2022 $1.2M -$6.2M -$0.80 -$2.9M -518.0% -87.5%
FY2021 $737.5K -$2.9M — — -352.0% -41.6%
FY2020 $370.6K -$2.7M — — -531.4% -141.0%
FY2019 $245.3K -$3.3M — -$1.1M -1358.1% -172.6%
FY2018 $568.0K -$2.7M — — -470.4% 313241.0%
FY2017 — -$151.3K — — — 17732.7%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

NutriBand Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

NutriBand Inc. has earned high returns on invested capital, averaging 288.3% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

NutriBand Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, NutriBand Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-85.70 per share.

NTRB stock: frequently asked questions

What is the intrinsic value of NutriBand Inc. (NTRB) stock?

Graham's formula only works with positive earnings. NutriBand Inc. reported diluted EPS of -$2.58 in fiscal 2026, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does NutriBand Inc. generate free cash flow?

NutriBand Inc. generated -$5.1M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2026. Free cash flow was positive in 0 of the last 6 reported years.

What is NTRB's return on invested capital?

Average ROIC over the last 10 fiscal years was 32983.6%, and average return on equity was -537.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this NTRB data come from?

From NutriBand Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Jun 11, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar orthopedic, prosthetic & surgical appliances & supplies stocks